Anti-APP (Ponezumab)-MC-Vc-PAB-MMAE ADC

CAT:

708-ADC-W-713

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

Description: This ADC product is comprised of an anti-APP monoclonal antibody conjugated via a MC-Vc linker to MMAE. The MMAE is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
CAS Number: 9007-83-4
Format: Solution
Shipping Conditions: Ice Packs
Storage Conditions: -20°C

Cat	Name
ADC-W-713	Anti-APP (Ponezumab)-MC-Vc-PAB-MMAE ADC
ADC-W-714	Anti-APP (Ponezumab)-MC-Vc-PAB-SN38 ADC
ADC-W-683	Anti-APP (Gantenerumab)-MC-Vc-PAB-MMAE ADC
ADC-W-701	Anti-APP (Solanezumab)-MC-Vc-PAB-MMAE ADC
ADC-W-695	Anti-APP (Aducanumab)-MC-Vc-PAB-MMAE ADC
ADC-W-707	Anti-APP (Bapineuzumab)-MC-Vc-PAB-MMAE ADC
ADC-W-689	Anti-APP (Crenezumab)-MC-Vc-PAB-MMAE ADC
ADC-S-012	MC-vc-PAB-MMAE
ADC-W-715	Anti-APP (Ponezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC
ADC-W-712	Anti-APP (Ponezumab)-MC-MMAF ADC